Talibegron Hydrochloride | CAS#178600-17-4 | CAS#146376-58-1 | β3 Adrenergic Receptor Agonist

MedKoo Cat#: 328078 | Name: Talibegron HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Talibegron, also known as D-2079; ICI-D-2079; SCH-417849; ZD-2079, is an β3 adrenergic receptor agonist potentially for the treatment of obesity and type 2 diabetes.

Chemical Structure

Talibegron HCl

CAS#178600-17-4 (HCl)

Theoretical Analysis

MedKoo Cat#: 328078

Name: Talibegron HCl

CAS#: 178600-17-4 (HCl)

Chemical Formula: C18H22ClNO4

Exact Mass:

Molecular Weight: 351.83

Elemental Analysis: C, 61.45; H, 6.30; Cl, 10.08; N, 3.98; O, 18.19

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

178600-17-4 (HCl) 146376-58-1 (free base)

Synonym

Talibegron HCl, Talibegron hydrochloride, D-2079, ICI-D-2079, SCH-417849, ZD-2079, D2079, ICI-D2079, SCH417849, ZD2079

IUPAC/Chemical Name

(R)-2-(4-(2-((2-hydroxy-2-phenylethyl)amino)ethoxy)phenyl)acetic acid hydrochloride

InChi Key

KCEFVYIWOQSJCH-LMOVPXPDSA-N

InChi Code

InChI=1S/C18H21NO4.ClH/c20-17(15-4-2-1-3-5-15)13-19-10-11-23-16-8-6-14(7-9-16)12-18(21)22;/h1-9,17,19-20H,10-13H2,(H,21,22);1H/t17-;/m0./s1

SMILES Code

O=C(O)CC1=CC=C(OCCNC[C@H](O)C2=CC=CC=C2)C=C1.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 351.83 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Kozłowska H, Schlicker E, Kozłowski M, Siedlecka U, Laudański J, Malinowska B. Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries. J Cardiovasc Pharmacol. 2005 Jul;46(1):76-82. PubMed PMID: 15965358. 2: Zelaszczyk D, Zakrzeska A, Kwolek G, Malinowska B, Schlicker E. A search for presynaptic beta3-adrenoceptors in the rat. Fundam Clin Pharmacol. 2005 Apr;19(2):147-53. PubMed PMID: 15810894. 3: Kozłowska H, Szymska U, Schlicker E, Malinowska B. Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery. Br J Pharmacol. 2003 Sep;140(1):3-12. PubMed PMID: 12967929; PubMed Central PMCID: PMC1574016. 4: Mallem MY, Gogny M, Gautier F, Bucas V, Desfontis JC. Evaluation of beta3-adrenoceptor-mediated relaxation in intact and endotoxin-treated equine digital veins. Am J Vet Res. 2003 Jun;64(6):708-14. PubMed PMID: 12828256. 5: Buemann B, Toubro S, Astrup A. Effects of the two beta3-agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects. Int J Obes Relat Metab Disord. 2000 Dec;24(12):1553-60. PubMed PMID: 11126205. 6: Brawley L, Shaw AM, MacDonald A. Role of endothelium/nitric oxide in atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta. Eur J Pharmacol. 2000 Jun 16;398(2):285-96. PubMed PMID: 10854841. 7: Brawley L, Shaw AM, MacDonald A. Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta. Br J Pharmacol. 2000 Feb;129(4):637-44. PubMed PMID: 10683187; PubMed Central PMCID: PMC1571885. 8: MacDonald A, McLean M, MacAulay L, Shaw AM. Effects of propranolol and L-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery. J Auton Pharmacol. 1999 Jun;19(3):145-9. PubMed PMID: 10511470. 9: Waghe M, Westwood R, Nunn G, Kalinowski A, Aldridge A. Urinary tract toxicity in rats following administration of beta 3-adrenoceptor agonists. Toxicol Pathol. 1999 Mar-Apr;27(2):165-70. PubMed PMID: 10207980. 10: Sarsero D, Molenaar P, Kaumann AJ. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium. Br J Pharmacol. 1998 Feb;123(3):371-80. PubMed PMID: 9504376; PubMed Central PMCID: PMC1565174. 11: Trayhurn P, Duncan JS, Rayner DV, Hardie LJ. Rapid inhibition of ob gene expression and circulating leptin levels in lean mice by the beta 3-adrenoceptor agonists BRL 35135A and ZD2079. Biochem Biophys Res Commun. 1996 Nov 12;228(2):605-10. PubMed PMID: 8920957. 12: Kaumann AJ, Molenaar P. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br J Pharmacol. 1996 Aug;118(8):2085-98. PubMed PMID: 8864547; PubMed Central PMCID: PMC1909870. 13: Hoffstedt J, Lönnqvist F, Shimizu M, Blaak E, Arner P. Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int J Obes Relat Metab Disord. 1996 May;20(5):428-34. PubMed PMID: 8696421. 14: Malinowska B, Schlicker E. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors. Br J Pharmacol. 1996 Mar;117(5):943-9. PubMed PMID: 8851515; PubMed Central PMCID: PMC1909427. 15: Pietri-Rouxel F, Strosberg AD. Pharmacological characteristics and species-related variations of beta 3-adrenergic receptors. Fundam Clin Pharmacol. 1995;9(3):211-8. Review. PubMed PMID: 7557816.